Us Bancorp \De\ Bio Techne Corp Transaction History

Us Bancorp \De\

$74.1 Billion
Q1 2025

A detailed history of Us Bancorp \De\ transactions in Bio Techne Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 156,583 shares of TECH stock, worth $8.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

156,583

Previous 151,926 3.07%

Holding current value

$8.32 Million

Previous $10.9 Million 16.11%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$58.47 - $78.75 $272,294 - $366,738	4,657 Added 3.07%	156,583 $9.18 Million
Q4 2024 Feb 05, 2025	BUY	$66.37 - $78.17 $44,667 - $52,608	673 Added 0.44%	151,926 $10.9 Million
Q3 2024 Oct 28, 2024	BUY	$70.96 - $82.35 $348,484 - $404,420	4,911 Added 3.36%	151,253 $12.1 Million
Q2 2024 Aug 06, 2024	BUY	$62.12 - $84.15 $397,940 - $539,064	6,406 Added 4.58%	146,342 $10.5 Million
Q1 2024 May 07, 2024	SELL	$65.98 - $77.09 $1.83 Million - $2.13 Million	-27,680 Reduced 16.51%	139,936 $9.85 Million
Q4 2023 Feb 09, 2024	BUY	$52.83 - $78.22 $897,528 - $1.33 Million	16,989 Added 11.28%	167,616 $12.9 Million
Q3 2023 Nov 03, 2023	SELL	$67.52 - $89.42 $435,504 - $576,759	-6,450 Reduced 4.11%	150,627 $10.3 Million
Q2 2023 Aug 09, 2023	SELL	$73.76 - $85.98 $355,006 - $413,821	-4,813 Reduced 2.97%	157,077 $12.8 Million
Q1 2023 May 09, 2023	SELL	$71.62 - $86.62 $164,296 - $198,706	-2,294 Reduced 1.4%	161,890 $12 Million
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $9.84 Million - $43 Million	121,950 Added 288.75%	164,184 $13.6 Million
Q3 2022 Oct 27, 2022	SELL	$282.54 - $391.85 $219,816 - $304,859	-778 Reduced 1.81%	42,234 $12 Million
Q2 2022 Aug 01, 2022	SELL	$322.67 - $449.65 $274,914 - $383,101	-852 Reduced 1.94%	43,012 $14.9 Million
Q1 2022 May 11, 2022	SELL	$353.85 - $487.79 $347,834 - $479,497	-983 Reduced 2.19%	43,864 $19 Million
Q4 2021 Feb 11, 2022	SELL	$456.15 - $525.06 $303,339 - $349,164	-665 Reduced 1.46%	44,847 $23.2 Million
Q3 2021 Nov 10, 2021	BUY	$444.87 - $538.88 $240,674 - $291,534	541 Added 1.2%	45,512 $22.1 Million
Q2 2021 Aug 05, 2021	BUY	$387.35 - $450.26 $442,353 - $514,196	1,142 Added 2.61%	44,971 $20.2 Million
Q1 2021 Apr 28, 2021	SELL	$314.62 - $411.0 $737,783 - $963,795	-2,345 Reduced 5.08%	43,829 $16.7 Million
Q4 2020 Feb 04, 2021	BUY	$246.9 - $321.87 $429,852 - $560,375	1,741 Added 3.92%	46,174 $14.7 Million
Q3 2020 Nov 10, 2020	BUY	$232.22 - $282.96 $366,443 - $446,510	1,578 Added 3.68%	44,433 $11 Million
Q2 2020 Aug 07, 2020	SELL	$185.43 - $279.56 $290,197 - $437,511	-1,565 Reduced 3.52%	42,855 $11.3 Million
Q1 2020 May 13, 2020	BUY	$161.17 - $221.51 $120,232 - $165,246	746 Added 1.71%	44,420 $8.42 Million
Q4 2019 Feb 04, 2020	SELL	$189.68 - $222.09 $87,252 - $102,161	-460 Reduced 1.04%	43,674 $9.59 Million
Q3 2019 Nov 08, 2019	BUY	$183.56 - $216.72 $171,445 - $202,416	934 Added 2.16%	44,134 $8.64 Million
Q2 2019 Aug 13, 2019	SELL	$188.72 - $215.43 $48,123 - $54,934	-255 Reduced 0.59%	43,200 $9.01 Million
Q1 2019 May 08, 2019	SELL	$136.09 - $200.44 $1.44 Million - $2.12 Million	-10,586 Reduced 19.59%	43,455 $8.63 Million
Q4 2018 Feb 13, 2019	BUY	$132.75 - $203.8 $37,833 - $58,083	285 Added 0.53%	54,041 $7.82 Million
Q3 2018 Nov 01, 2018	SELL	$147.44 - $204.11 $126,503 - $175,126	-858 Reduced 1.57%	53,756 $11 Million
Q2 2018 Aug 08, 2018	SELL	$144.9 - $165.58 $33,906 - $38,745	-234 Reduced 0.43%	54,614 $8.08 Million
Q1 2018 May 08, 2018	SELL	$131.46 - $151.04 $563,700 - $647,659	-4,288 Reduced 7.25%	54,848 $8.29 Million
Q4 2017 Feb 02, 2018	SELL	$121.17 - $134.75 $157,521 - $175,175	-1,300 Reduced 2.15%	59,136 $7.66 Million
Q3 2017 Nov 13, 2017	BUY	$113.59 - $123.78 $6.86 Million - $7.48 Million	60,436	60,436 $7.31 Million

Others Institutions Holding TECH

# of Institutions

628

Shares Held

160M

Call Options Held

90K

Put Options Held

14.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.08B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account